---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-035184"
form_type: "8-K"
ticker: null
cik: "0000727207"
company_name: "Accelerate Diagnostics, Inc"
filed_at: "2025-04-15T23:59:59+00:00"
generated_at: "2026-05-23T15:12:53.259708+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Accelerate Diagnostics adds Shalhoub, Nathan to board; forms strategic alternatives committee

## Summary
- Elected Paul Shalhoub and Gilbert Nathan as independent directors effective April 10, 2025; each receives $25k monthly cash fee.
- Board formed a Special Committee (Burris, Shalhoub, Nathan) to oversee strategic alternatives to maximize value, no assurances given.
- Approved retention bonuses: CFO David Patience $159,650 and CTO Lawrence Mertz $171,458, payable soon with 180-day clawback.
- Nathan appointed per director nomination rights from note purchase agreement related to 16% Super-Priority Senior Secured PIK Notes due 2025.

## SEC filing metadata
- accession: 0001104659-25-035184
- form_type: 8-K
- cik: 0000727207
- company_name: Accelerate Diagnostics, Inc
- filed_at: 2025-04-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/727207/000110465925035184/0001104659-25-035184-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/727207/000110465925035184/tm2512407d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-035184
- JSON: https://secwatch.observer/filing/0001104659-25-035184.json
- Plain text: https://secwatch.observer/filing/0001104659-25-035184.txt

## Key facts
- Executive change
  Paul Shalhoub was elected as Director at Accelerate Diagnostics, Inc.
  - Action: elected
  - Role: Director
  source text: unanimously elected Paul Shalhoub and Gilbert Nathan to serve as new directors, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/727207/000110465925035184/0001104659-25-035184-index.htm
- Executive change
  Gilbert Nathan was elected as Director at Accelerate Diagnostics, Inc.
  - Action: elected
  - Role: Director
  source text: unanimously elected Paul Shalhoub and Gilbert Nathan to serve as new directors, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/727207/000110465925035184/0001104659-25-035184-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.